Metformax

Metformin Hydrochloride, the active ingredient in Metformax, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑sugar control. Metformax is sourced from the European Union and complies with international quality standards.

GNH USA supplies Metformax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformax belongs to the biguanide class and is used to manage disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial glucose levels to improve glycaemic control. - Impaired glucose tolerance: reduces the risk of progression to overt diabetes. - Polycystic ovary syndrome: improves insulin sensitivity and may help regularise menstrual cycles.

Metformax may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: when combined with insulin or secretagogues. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: elevated liver enzymes. - Skin rash or hypersensitivity: including Stevens‑Johnson syndrome. - Pancreatitis: inflammation of the pancreas.

Before initiating Metformax, several safety considerations should be reviewed. - Renal function assessment: ensure adequate kidney clearance before use. - Monitor blood glucose: adjust therapy based on glycaemic response. - Evaluate hepatic function: avoid in severe liver disease. - Use caution in elderly patients: increased risk of lactic acidosis. - Avoid in patients with severe heart failure: contraindicated due to metabolic risk. - Store at ambient temperature: keep in the original pack, protect from moisture.

Metformax can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate lactic acidosis. - Alcohol: increases risk of metabolic acidosis. - Cimetidine: can raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: may affect renal function. - Corticosteroids: can raise blood glucose levels. - Oral contraceptives: may slightly increase metformin levels.